Can renal disease cause metabolic acidosis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 22, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Renal Disease as a Cause of Metabolic Acidosis

Yes, renal disease is a significant cause of metabolic acidosis, particularly when glomerular filtration rate (GFR) falls below 60 mL/min/1.73 m² (stage 3 CKD or greater). 1

Pathophysiology of Renal-Induced Metabolic Acidosis

Metabolic acidosis in chronic kidney disease (CKD) occurs through several mechanisms:

  1. Impaired acid excretion: The kidneys fail to adequately excrete acid produced by normal metabolic processes 1
  2. Reduced ammoniagenesis: Damaged kidneys have decreased capacity to synthesize ammonia, which is essential for acid buffering 2
  3. Bicarbonate loss: Direct loss of bicarbonate from the kidney 1
  4. Reduced bicarbonate regeneration: Impaired ability to regenerate bicarbonate 3

Clinical Presentation

Metabolic acidosis in CKD typically presents with:

  • Serum bicarbonate concentrations ranging from 12 to 22 mEq/L (mmol/L) 4
  • Usually mild to moderate in degree 4
  • Severity correlates with degree of renal impairment 4
  • Can be high-anion-gap or normal anion-gap variety 4
  • Becomes more prevalent when GFR falls below 20-25% of normal 4

Diagnosis

Metabolic acidosis should be suspected in patients with CKD, particularly those with:

  • eGFR <60 mL/min/1.73 m² 1
  • Serum bicarbonate <22 mmol/L 5
  • Elevated anion gap: [Na⁺] - ([Cl⁻] + [HCO₃⁻]) >12 mEq/L 5
  • Low blood pH (<7.35) 1

Adverse Effects of Metabolic Acidosis in CKD

Untreated metabolic acidosis can lead to:

  • Bone demineralization and metabolic bone disease 3, 6
  • Muscle wasting and protein degradation 4, 6
  • Impaired growth in children 7
  • Insulin resistance 4
  • Accelerated progression of kidney disease 6, 2
  • Increased inflammation 6
  • Increased mortality 7

Management

Monitoring

  • Regular monitoring of serum electrolytes and bicarbonate levels 1
  • Assessment for complications of CKD (Table 11.1) when eGFR <60 mL/min/1.73 m² 1

Treatment

  1. Oral sodium bicarbonate:

    • Indicated for treatment of metabolic acidosis in severe renal disease 8
    • Recommended dose: 2-4 g/day (25-50 mEq/day) divided into 2-3 doses 5
    • Target serum bicarbonate level of at least 22 mmol/L 5
  2. Dietary modifications:

    • Protein intake of 0.8 g/kg body weight per day for non-dialysis CKD patients 1
    • Avoid high protein intake (>1.3 g/kg/day) as it can accelerate kidney function decline 1
    • Restriction of dietary sodium (<2,300 mg/day) 1
    • Individualization of dietary potassium 1
  3. IV sodium bicarbonate:

    • Consider for severe acidosis (pH <7.2) 5
    • Used when oral therapy is not possible 5
    • Requires careful monitoring of fluid status and electrolytes 5

Complications of Treatment

  • Volume overload 7
  • Exacerbation of hypertension 7
  • Hypokalemia 5
  • Hypocalcemia 5
  • Potential for vascular calcifications 7

Clinical Pearls

  • Metabolic acidosis is present in the majority of patients with advanced CKD (GFR <20-25% of normal) 4
  • Even mild acidosis can have substantial adverse effects on multiple organ systems 6
  • Correction of acidosis with sodium bicarbonate may slow the progression of CKD 2
  • The anion gap should be corrected for albumin for accurate diagnosis 5
  • Metabolic acidosis is listed as a complication to screen for in patients with CKD in multiple guidelines 1

By addressing metabolic acidosis in CKD patients, clinicians can potentially improve outcomes related to bone health, muscle mass, kidney disease progression, and mortality.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Acidosis and progression of chronic kidney disease.

Current opinion in nephrology and hypertension, 2010

Research

Metabolic acidosis of CKD: diagnosis, clinical characteristics, and treatment.

American journal of kidney diseases : the official journal of the National Kidney Foundation, 2005

Guideline

Metabolic Acidosis Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Metabolic Acidosis in CKD: Pathogenesis, Adverse Effects, and Treatment Effects.

International journal of molecular sciences, 2024

Research

Consequences and therapy of the metabolic acidosis of chronic kidney disease.

Pediatric nephrology (Berlin, Germany), 2011

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.